Printer Friendly

Neovasc announces follow-up data for Neovasc Reducer published in JACC.

Neovasc announced that the Journal of the American College of Cardiology, or JACC, published new, peer reviewed Reducer data describing the long-term clinical and anatomical follow-up of patients with severe angina pectoris treated with the Neovasc Reducer 12 years ago. The publication is entitled: "First-in-Human Use of Coronary Sinus Reducer in Patients With Refractory Angina." The publication is based on a prospective, non-randomized, single-arm anatomic and clinical evaluation of patients who underwent Reducer implantation at a single medical center as part of the first-in-human clinical study1. Seven patients described in the article were electively implanted with the Reducer in 2005. All had chronic refractory angina and evidence of reversible myocardial ischemia. At 12 years, all seven patients reported sustained improvement of angina class compared with baseline status.

COPYRIGHT 2018 The Fly
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:The Fly
Date:Dec 11, 2018
Previous Article:Gogo reports positive results of 2Ku de-icing modifications.
Next Article:Omeros announces research collaboration with University of Cambridge.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters